Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.21M | -17.57M | -18.92M | -20.26M | -21.60M |
| Total Depreciation and Amortization | 615.80K | 657.70K | 699.60K | 698.10K | 696.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.25M | 4.81M | 3.37M | 3.51M | 3.65M |
| Change in Net Operating Assets | -1.63M | -1.24M | -848.00K | -461.30K | -74.60K |
| Cash from Operations | -10.98M | -13.34M | -15.70M | -16.52M | -17.33M |
| Capital Expenditure | -1.20K | 6.70K | 14.60K | -45.10K | -104.80K |
| Sale of Property, Plant, and Equipment | 17.80K | 20.60K | 23.40K | 23.40K | 23.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 16.40K | 32.80K | 32.80K | 32.80K |
| Other Investing Activities | -1.05M | -675.00K | -300.00K | -225.00K | -150.00K |
| Cash from Investing | -1.03M | -631.40K | -229.40K | -214.10K | -198.80K |
| Total Debt Issued | -- | 670.00K | 1.34M | 2.83M | 4.31M |
| Total Debt Repaid | -1.49M | -1.35M | -1.21M | -1.25M | -1.28M |
| Issuance of Common Stock | 8.25M | 12.52M | 16.78M | 15.27M | 13.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.76M | 11.84M | 16.92M | 16.85M | 16.79M |
| Foreign Exchange rate Adjustments | -96.60K | -74.30K | -52.00K | -75.10K | -98.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.35M | -2.21M | 933.40K | 49.10K | -835.20K |